Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease

NCT02378688 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: MT-1303
DRUG: Placebo

Sponsor

Tanabe Pharma Corporation